Drug - Clinda-derm
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Clindamycin Phosphate
Multiple ingredients are in alphabetical order.

Strength - EQ 1% BASE
The potency of the active ingredient(s), Clindamycin Phosphate. May repeat for multiple part products.

Applicant - PADDOCK
The firm name holding legal responsibility for Clinda-derm. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 063329
The FDA assigned number to Clinda-derm. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Clinda-derm. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 30, 1992
The date Clinda-derm was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Clinda-derm. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Clinda-derm is in. Format is RX, OTC, DISCN.

Applicant Full Name - Paddock Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Clinda-derm.